
### [NCIT:C40077](http://purl.obolibrary.org/obo/NCIT_C40077)
**Label:** Malignant Ovarian Clear Cell Tumor

**Subclasses:** [NCIT:C40078](http://purl.obolibrary.org/obo/NCIT_C40078) (Ovarian Clear Cell Adenocarcinoma), [NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma), [NCIT:C7980](http://purl.obolibrary.org/obo/NCIT_C7980) (Ovarian Clear Cell Cystadenocarcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.03%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) 47.86%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39058](http://purl.obolibrary.org/obo/NCIT_C39058) (EGF Signaling Pathway))) 47.86%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39056](http://purl.obolibrary.org/obo/NCIT_C39056) (Vesicle Transport Pathway))) 47.86%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 47.86%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39054](http://purl.obolibrary.org/obo/NCIT_C39054) (Extracellular Matrix Binding Pathway))) 47.86%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 47.86%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39021](http://purl.obolibrary.org/obo/NCIT_C39021) (Cell Migration Pathway))) 47.86%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39016](http://purl.obolibrary.org/obo/NCIT_C39016) (EGF Receptor Downregulation by CBL Pathway))) 47.86%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39013](http://purl.obolibrary.org/obo/NCIT_C39013) (Estrogen Receptor Regulation by CARM1 Pathway))) 47.86%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 47.86%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 47.86%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 47.86%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39004](http://purl.obolibrary.org/obo/NCIT_C39004) (B-Cell Survival Pathway))) 47.86%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C38999](http://purl.obolibrary.org/obo/NCIT_C38999) (BARD1 Pathway))) 47.86%


